TABLE 3.
Comparison of the modified (tTAnls) and unmodified (tTA) transactivator for activation of CAT expression in COS-1 cellsa
| Vector transfected with pUtetO-CATwt | Tc (2 μg/ml) | Avg CAT activity ± SD (U) | Fold regulation |
|---|---|---|---|
| pUHD15-1 (pU-CMV-tTA) | — | 3,823 ± 113 | 48 |
| + | 80 ± 13 | ||
| pU-CMV-tTAnls | — | 55,944 ± 6,394 | 76 |
| + | 739 ± 53 | ||
| pCMV-βgal | — | <1 ± 0.5 | |
| None (mock) | — | <1 ± 0.5 |
COS-1 cell cultures in 60-mm-diameter dishes were cotransfected with 2.5 μg of pUtetO-CATwt and 2.5 μg of either pUHD15-1 or pU-CMV-tTAnls, using the DEAE-dextran method. As a control, the same amount of pCMV-βgal was used with pUtetO-CATwt. Where indicated, cells were incubated in the presence of 2 μg of tetracycline (Tc) per ml for the course of the transfection. CAT activity was determined by using various amounts of protein extracts that yielded activities within a linear range. One unit of CAT activity is defined as nanomoles of chloramphenicol acetylated by 10 μg of protein per hour; values are averages of duplicate transfection experiments. Fold regulation was calculated after normalization by subtracting the background CAT activity in mock-transfected cell extracts.